METHODE ELECTRONICS INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data METHODE ELECTRONICS INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	817	908	1,000	1,024	1,088	1,164	1,180	1,115	1,048	1,019
Cost of revenue	598	669	735	741	814	899	916	936	885	817
Gross profit	218	240	266	283	274	265	264	179	163	202
Research and development	27.8	37.9	41.2	34.9	35.7	35.7	35	49.1	41.8	37.5
Selling, general and administrative	105	116	143	117	127	134	155	161	164	170
Operating income	111	118	107	147	128	112	90.4	-112	-23.9	8.8
Other non-operating income	4.7	6.4	5.1	11.7	12.2	10.3	2.4	0.6	-4.2	3.8
Pre-tax income	116	124	104	149	135	119	90.1	-128	-50.1	-10.7
Income tax	23	66.6	12	25.3	12.6	16.3	13	-4.8	12.5	25
Net income to minority interests	0
Net income	92.9	57.2	91.6	123	122	102	77.1	-123	-62.6	-35.7
EBITDA	135	146	150	195	179	164	140	-54.1	34.6	67.6
EPS, basic		1.54	2.45	3.28	3.22	2.74	2.14	-3.48	-1.77	-1.01
EPS, diluted		1.52	2.43	3.26	3.19	2.70	2.10	-3.48	-1.77	-1.01
Shares, basic (weighted)	37.3	37.3	37.4	37.6	38	37.2	36	35.5	35.3	35.5
Shares, diluted (weighted)	37.5	37.5	37.7	37.8	38.3	37.8	36.8	35.5	35.3	35.5
Dividend per share	0.36	0.40	0.44	0.44	0.44	0.56	0.56	0.56	0.56	0.22

Balance sheet

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	294	246	83.2	217	233	172	157	162	104	140
Receivables	165	203	219	189	283	273	314	263	241	257
Inventory	57.9	84.1	117	131	124	159	160	186	194	179
Other current assets	12.5	14.8	20	15.9	22.6	16.9	20.5	18.7	17.1	21.2
Total current assets	530	550	454	566	674	629	664	638	560	600
Property, plant and equipment	90.6	162	192	202	204	197	220	212	222	209
Lease right-of-use assets			0	23.5	22.3	20	28.4	26.7	23.7	20.5
Goodwill	1.6	59.2	233	232	236	233	302	170	173	175
Intangible assets	6.6	61	265	245	229	208	257	257	238	219
Other non-current assets	83.1	204	778	805	793	760	915	766	746	706
Total assets	704	916	1,232	1,371	1,467	1,389	1,579	1,404	1,306	1,306
Accounts payable	75.3	89.5	91.9	73.8	123	109	139	132	126	134
Accrued liabilities	18.7	22.8	20.1	19.1	33.5	30	36.7	38	32	49.1
Short-term debt	0	4.4	15.7	15.3	14.9	13	3.2	0.2	0.2	0.2
Total current liabilities	124	157	181	144	223	189	228	231	233	254
Long-term debt		53.4	277	337	225	198	304	331	317	325
Lease liabilities			0	20.4	17.5	14.8	21.8	20.6	18.2	14.8
Other non-current liabilities	2.6	14.6	14.8	15.3	20.5	14	14.3	16.8	16.9	5.8
Total liabilities	163	286	542	587	549	475	626	638	613	629
Total debt	27	53.4	293	352	240	211	307	331	318	325
Paid-in capital	132	137	150	151	158	169	181	184	192	200
Retained earnings	427	472	545	652	746	764	773	612	524	479
Treasury stock	-11.5	-11.5	-11.5	-11.5	-11.5	-11.5	-11.5	-11.5	-11.5	-11.5
Other comprehensive income	-25.7	13.9	-13.6	-26.9	6.1	-26.8	-19	-36.7	-29.8	-8.8
Shareholders' equity	541	630	690	783	918	914	942	766	693	678
Minority interests	0
Total equity	541	630	690	783	918	914	942	766	693	678
Total liabilities and equity	704	916	1,232	1,371	1,467	1,389	1,579	1,404	1,306	1,306
Shares outstanding	38.1

Cash flow statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	92.9	57.2	91.6	123	122	102	77.1	-123	-62.6	-35.7
Depreciation and amortization	24.3	28.1	43.3	48.3	51.5	52.6	49.5	57.9	58.5	58.8
Stock-based compensation	12.4	4	14	0.3	6.8	11.8	11.5	3.6	7.4	8.5
Deferred income tax	-3.9	1	-3.8	7.4	-9.1	-2.4	-4	-21.5	-5.5	1.3
Change in receivables	5.6	2.8	1.5	27.4	-81.9	-2	-21	48	22.7	-12.3
Change in inventory	7.4	-7.2	-3.9	-15.8	11.3	-39.3	1.1	-41.1	-25.7	7.9
Change in payables	11.1	39.8	-23.1	-47.5	59.5
Cash from operations	145	118	102	141	180	98.8	133	47.5	26.4	38
Capital expenditures	-22.4	-47.7	-49.8	-45.1	-24.9	-38	-42	-50.2	-41.6	-22.4
Acquisitions	0	-131	-422				-115
Cash from investing	-21.7	-179	-471	-44.5	-24.8	-37.4	-153	-17.5	-32.9	1.3
Stock issued	2.7	0.3	0		0.8	0.5	1.5
Share buybacks	-9.8	0	0		-6.7	-64.5	-48.1	-13.7	-1.6	0
Dividends paid	-13.7	-14.7	-16.3	-16.3	-17.4	-20.4	-19.8	-19.9	-20.4	-8.3
Cash from financing	-47	-12.7	217	41.7	-143	-115	3.2	-18.9	-58.9	-14.2
Exchange rate effect	-10.3	26	-11.5	-3.7	3.8	-8	2.1	-6.6	7.5	10.9
Net change in cash	66.2	-47.9	-163	134	15.9	-61.2	-15	4.5	-57.9	36
Free cash flow	123	70.1	52.2	95.5	155	60.8	90.8	-2.7	-15.2	15.6
Interest paid	1.1	2.4	8.8	9.9	5.3	3.6	5.6	17	23.4	20.9
Income taxes paid	19	20.2	27.8	21.1	16	32.3	25.6	15	22.3	24.6

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to August 1, 2026; growth uses fiscal years. Valuation uses the share price of $14.51 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	19.8%	Gross profit / revenue.
Operating margin	0.4%	Operating income / revenue.
EBITDA margin	4.8%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-1.1%	Pre-tax income / revenue.
Net margin	-3.5%	Net income / revenue.
FCF margin	-1.3%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	0.5%	Cash from operations / revenue.
Return on equity (ROE)	-5.5%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-2.9%	Net income / average total assets.
Return on invested capital (ROIC)	0.4%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	17.2%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.9%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.8%	Capital expenditures / revenue.
D&A / revenue	4.4%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-2.8%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-4.8%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-1.3%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	23.7%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-8.5%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-5.9%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income CAGR, 3y	-54.0%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	-41.5%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	95.4%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-21.5%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-17.7%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	43.9%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-34.1%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-26.7%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow CAGR, 3y	-44.4%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-36.8%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	-60.7%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	-26.8%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	-12.9%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-2.3%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-10.4%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-5.9%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	0.0%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-6.1%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-2.3%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.5%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-1.1%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-1.5%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.41x	Current assets / current liabilities.
Quick ratio	1.54x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.48x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.47x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	24.6%	Total debt / total assets.
Liabilities / assets	47.5%	Total liabilities / total assets.
Net debt	$194.3M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	3.87x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Working capital	$342.1M	Current assets - current liabilities.
Goodwill and intangibles / assets	30.5%	(Goodwill + intangible assets) / total assets.
Tangible book value	$278.2M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.83x	Revenue / average total assets.
Fixed asset turnover	5.15x	Revenue / average property, plant and equipment.
Inventory turnover	4.54x	Cost of revenue / average inventory.
Days inventory	80 days	365 x average inventory / cost of revenue.
Receivables turnover	4.07x	Revenue / average receivables.
Days sales outstanding	90 days	365 x average receivables / revenue.
Days payables	60 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	110 days	Days inventory + days sales outstanding - days payables.
Capex / operating cash flow	360.8%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$1.03	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$29.27	Revenue / diluted weighted shares.
FCF per share	-$0.37	Free cash flow / diluted weighted shares.
Operating cash flow per share	$0.14	Cash from operations / diluted weighted shares.
Book value per share	$18.59	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$7.80	Tangible book value / shares outstanding.
Cash per share	$3.26	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$514.7M	Share price x shares outstanding.
Enterprise value	$709.0M	Market cap + total debt - cash - short-term investments.
P/S	0.49x	Market cap / revenue.
P/B	0.78x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	1.85x	Market cap / tangible book value, when positive.
P/OCF	101x	Market cap / cash from operations, when positive.
EV/Sales	0.68x	Enterprise value / revenue.
EV/EBIT	187x	Enterprise value / operating income, when both are positive.
EV/EBITDA	14.1x	Enterprise value / EBITDA, when both are positive.
FCF yield	-2.6%	Free cash flow / market cap.
Earnings yield	-7.1%	Net income / market cap (the inverse of P/E).
Dividend yield	1.4%	Dividends paid over the period / market cap.
Shareholder yield	1.4%	(Dividends paid + share buybacks) / market cap.

What was METHODE ELECTRONICS INC's revenue in fiscal 2026?

METHODE ELECTRONICS INC reported revenue of $1.02B for fiscal 2026, 2.8% lower than the year before.

Was METHODE ELECTRONICS INC profitable in fiscal 2026?

No. It reported a net loss of $35.7M.

How much free cash flow did METHODE ELECTRONICS INC generate in fiscal 2026?

Cash from operations of $38.0M minus capital expenditures of $22.4M left free cash flow of $15.6M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to METHODE ELECTRONICS INC